Medical Specialties Distributors (MSD), a portfolio company of private equity firm Water Street Healthcare Partners, has acquired Medical Technology Resources (MTR).
Headquartered in Columbus, Ohio, MTR specialises in providing infusion pumps and related products, as well as biomedical and billing services to alternate-site healthcare providers.
“MTR’s unique product offerings and strong presence in the Midwest enhances our leadership position in the growing home infusion and oncology markets,” says James Beck, president and chief executive, MSD. “Over the past three years, we have grown our national footprint through partnerships with multi-site health care providers and strategic relationships with leading manufacturers. This acquisition is one more step toward our goal of creating a stronger growth platform for MSD.”
MSD is a US provider of infusion products, supplies, biomedical and distribution services, and technology solutions to the home infusion and oncology markets. Since partnering in 2010 with Water Street Healthcare Partners, a strategic private equity firm focused exclusively on healthcare, the company has grown through organic and strategic initiatives as demand for intravenous (IV) therapy in the home has increased. Today, MSD serves a broad base of 2,500 customers, including the nation’s leading specialty pharmacies, home infusion companies and oncology clinics. It has a nationwide network of ISO certified biomedical equipment service and product distribution centres.
“We are very excited about MTR becoming a part of MSD because it creates a stronger partner for our customers,” says Andy Amicon, chief executive, Medical Technology Resources. “Our customers in long-term care and home infusion pharmacies will have access to more products and services, a larger distribution network, and increased biomedical service centres to more efficiently meet their needs.”
Rob Womsley, a partner with Water Street and chairman of MSD, says: “We identified MTR as an ideal acquisition for MSD several years ago. MTR builds on MSD’s core capabilities in product distribution and biomedical services and increases its presence in the Midwest geography. Longer-term, it expands MSD’s unique position as the leading national distributor dedicated to serving the growing numbers of home infusion providers.”
